Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Interest Expenses (2016 - 2025)

Icu Medical (ICUI) has disclosed Interest Expenses for 10 consecutive years, with $19.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 19.75% year-over-year to $19.8 million, compared with a TTM value of $62.4 million through Dec 2025, down 13.7%, and an annual FY2021 reading of $858000.0, down 51.06% over the prior year.
  • Interest Expenses was $19.8 million for Q3 2025 at Icu Medical, down from $20.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $24.7 million in Q3 2024 and bottomed at $161000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $16.0 million, with a median of $20.8 million recorded in 2022.
  • The sharpest move saw Interest Expenses crashed 78.86% in 2021, then skyrocketed 12489.88% in 2022.
  • Year by year, Interest Expenses stood at $366000.0 in 2021, then soared by 5678.96% to $21.2 million in 2022, then increased by 14.3% to $24.2 million in 2023, then grew by 2.1% to $24.7 million in 2024, then decreased by 19.75% to $19.8 million in 2025.
  • Business Quant data shows Interest Expenses for ICUI at $19.8 million in Q3 2025, $20.5 million in Q2 2025, and $22.0 million in Q1 2025.